Another effort on pancreatic cancer flops, as Boston Biomedical cans phase 3 combo test

Submitted by admin on July 2, 2019 - 10:30am

Source:

Fierce Biotech

News Tags:

Boston Biomedical

clinical trials

pancreatic cancer

napabucasin

Headline:

Another effort on pancreatic cancer flops, as Boston Biomedical cans phase 3 combo test

snippet:

Boston Biomedical is halting a late-stage study of its investigational drug, alongside older chemo therapies, after it failed to help pancreatic cancer patients.

Search form

You are here

Another effort on pancreatic cancer flops, as Boston Biomedical cans phase 3 combo test

Another effort on pancreatic cancer flops, as Boston Biomedical cans phase 3 combo test